21,924 Shares in KORU Medical Systems, Inc. (NASDAQ:KRMD) Bought by Balyasny Asset Management L.P.

Balyasny Asset Management L.P. bought a new stake in KORU Medical Systems, Inc. (NASDAQ:KRMD) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 21,924 shares of the company’s stock, valued at approximately $84,000.

Other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its holdings in KORU Medical Systems by 2,770.7% during the fourth quarter. JPMorgan Chase & Co. now owns 17,712 shares of the company’s stock valued at $68,000 after acquiring an additional 17,095 shares during the period. Virtu Financial LLC bought a new position in shares of KORU Medical Systems in the fourth quarter worth about $73,000. Y Intercept Hong Kong Ltd acquired a new position in shares of KORU Medical Systems during the 4th quarter worth about $104,000. Raymond James Financial Inc. bought a new stake in KORU Medical Systems during the 4th quarter valued at approximately $118,000. Finally, Schonfeld Strategic Advisors LLC bought a new stake in KORU Medical Systems during the 4th quarter valued at approximately $143,000. Institutional investors own 58.60% of the company’s stock.

Wall Street Analysts Forecast Growth

KRMD has been the subject of several research reports. Piper Sandler reduced their price objective on KORU Medical Systems from $4.50 to $3.50 and set a “neutral” rating for the company in a research report on Thursday, May 8th. B. Riley upgraded shares of KORU Medical Systems to a “strong-buy” rating in a research note on Thursday, March 13th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $4.50.

KORU Medical Systems Trading Down 3.6%

KORU Medical Systems stock opened at $2.95 on Monday. The business has a 50 day moving average price of $2.64 and a two-hundred day moving average price of $3.41. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. KORU Medical Systems, Inc. has a 12 month low of $1.86 and a 12 month high of $5.05. The stock has a market cap of $136.12 million, a price-to-earnings ratio of -11.80 and a beta of 0.39.

KORU Medical Systems (NASDAQ:KRMD) last issued its earnings results on Wednesday, May 7th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). The firm had revenue of $9.64 million during the quarter, compared to analyst estimates of $8.86 million. KORU Medical Systems had a negative net margin of 37.42% and a negative return on equity of 24.60%. As a group, equities analysts forecast that KORU Medical Systems, Inc. will post -0.13 EPS for the current year.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.